DalsnaFinance › Analyst accuracy › Wells Fargo › RARE target
Wells Fargo raises Ultragenyx Pharma price target on phase 3 data
Wells Fargo raised its price target on Ultragenyx Pharma stock (NASDAQ:RARE) to $50.00 from $46.00
A fact about what Wells Fargo published, as reported by Investing.com, not a recommendation from Dalsna Finance; Wells Fargo is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.